ReviewCancers2022

Management of Immune-Related Adverse Events from Immune-Checkpoint Inhibitors in Advanced or Metastatic Renal Cell Carcinoma.

Katharina Leucht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.